dividend

A dividend is a cash payout that serves as a way for companies to share the profits they’ve accumulated through their operations. These payouts are drawn from earnings and cash flow paid to the shareholders of the company. Commonly these dividends are paid quarterly, although they may also be paid annually or even monthly as well. A dividend can produce as much as a quarter of your total return over long periods. Some good companies reinvest profits instead of paying a dividend. But fraudulent and failing companies hardly ever pay a dividend. So if you only buy stocks that pay dividends, you’ll automatically stay out of almost all the market’s worst stocks. For a true measure of stability, focus on companies that have maintained or raised their dividends during recessions and stock market downturns. These firms leave themselves enough room to handle periods of earnings volatility. By continually rewarding investors, and retaining enough cash to finance their businesses, they provide an attractive mix of safety, income and growth. Dividends are an important contributor to your long-term gains, and dividend-paying stocks tend to expose you to less risk than non-dividend-payers. That’s why the majority of your stocks should be dividend-payers at all times. As you get older and closer to retirement, you should raise the proportion of dividend-paying stocks in your portfolio, to cut risk and improve the stability of your investment results. To maximize your investment returns with the least risk, follow TSI Network and use our three-part Successful Investor strategy:

  1. Invest mainly in well-established companies;
  2. Spread your money out across most if not all of the five main economic sectors (Manufacturing & Industry; Resources & Commodities; Consumer; Finance; Utilities);
  3. Downplay or avoid stocks in the broker/media limelight.

Discover how to put an extra strength in your portfolio with our specific advice on how to identify high-quality dividend stocks. It’s all in our newly updated report, Dividend Paying Stocks: How High Dividend Stocks Can Supercharge Your Income Investing. And it’s yours FREE!

Read More Close
When choosing stocks for the Finance sector of their portfolio, most investors gravitate toward banks. However, there are many high quality, non-bank financial stocks that you should also consider. For instance, we think Intact Financial offers investors a particularly unique combination of value and growth.

For the 12 months ended October 3, 2022, while the S&P/TSX Composite Index fell 5.6%, Intact shares climbed an impressive 19.9%....
During the pandemic, both Domino’s Pizza and Chipotle implemented savvy strategies to support their businesses. Now, as the economy normalizes, we think each is well-positioned to capitalize on its popular offerings to keep attracting dine-in, pick-up and takeout customers....
Eli Lilly discovers, develops, manufactures, and markets human pharmaceutical products—and it now has an obesity drug with a bright future that’s being fast-tracked by the FDA.


ELI LILLY & CO., $329.29, is a buy. The company (New York symbol LLY; TSINetwork Rating: Above Average) (www.lilly.com; Shares o/s: 950.2 million; Market cap: $318.3 billion; Dividend yield: 1.2%) said that the U.S....
MERCK & CO. INC., $93.26, is a #1 Power Buy for 2022. The drugmaker (New York symbol MRK; TSINetwork Rating: Above Average) (www.merck.com; Shares outstanding: 2.5 billion; Market cap: $239.7 billion; Dividend yield: 3.0%) has now exercised an option to jointly develop and potentially sell an mRNA-based cancer vaccine along with Moderna (symbol MRNA on Nasdaq).


The vaccine, mRNA-4157, is being tested in conjunction with Merck’s blockbuster cancer immunotherapy Keytruda, in a mid-stage trial for patients with high-risk melanoma....
We continue to see attractive investment opportunities for our subscribers in top drug stocks—and that includes AbbVie Inc. At the same time, over the years, we’ve found that spinoffs are about as close as you can get to a sure thing in investing. It’s one key reason why we think AbbVie—itself a spinoff—has further gains ahead for investors. We recommend this stock as a Power Buy.


ABBVIE INC., $143.13, is a buy. The company (New York symbol ABBV; TSINetwork Rating: Above Average) (www.abbvie.com; Shares outstanding: 1.8 billion; Market cap: $255.7 billion; Dividend yield: 3.9%) was formed on January 3, 2013, when Abbott Laboratories (symbol ABT on New York) split into two publicly traded companies.


Since its spinoff from Abbott Laboratories, AbbVie has depended heavily on its Humira drug to drive both its sales and earnings....
INTEL CORP. $26 is a buy. The company (Nasdaq symbol INTC; Manufacturing & Industry sector; Shares o/s: 4.1 billion; Market cap: $106.6 billion; Dividend yield: 5.6%; Takeover Target Rating: Medium; www.intel.com) acquired Israel-based Mobileye, which specializes in computer systems and chips for self-driving cars, in 2017 for $15.7 billion.


Intel now plans to sell 41 million shares in Mobileye to the public for $18 to $20 each....

KAR AUCTION SERVICES INC. $14 is a buy. The company (New York symbol KAR; Manufacturing & Industry sector; Shares outstanding: 115.8 million; Market cap: $1.6 billion; No dividend paid; Takeover Target Rating: Medium; www.karglobal.com) sells used and salvaged vehicles at physical auction sites in the U.S., Canada, Mexico, Europe, and the U.K.


On June 28, 2019, the company completed its spinoff of IAA Inc....
Pharmaceutical giant Johnson & Johnson still plans to spin off its consumer operations in 2023 as a new firm called Kenvue.


Even though Kenvue’s products are less profitable than prescription drugs and medical devices, it owns some of the world’s best-known brands and generates steady cash flows....
IAC INC. $48 is a buy. The company, formerly called IAC/InterActive Corp., (Nasdaq symbol IAC; Manufacturing & Industry Sector; Shares outstanding: 89.2 million; Market cap: $4.3 billion; No dividend paid; Takeover Target Rating: Lowest; www.iac.com) owns several online businesses, including U.S....

Internet media company IAC (see box) has a long history of spinning off its smaller businesses as they mature. Two of its latest spinoffs—Vimeo and Match Group—are well off their recent peaks during the current market turmoil. We think they’re worth holding, while IAC remains a solid pick for aggressive investors.


VIMEO INC....